Donor Deferral and Lookback

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 182 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Current Good Manufacturing Practices for Transfusion Services. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Current Good Manufacturing Practices for Transfusion Services (online CE course)
Donor Deferral and Lookback

Donor deferral requirements and lookback procedures are described in CFR Title 21 Part 610. Section 610.41 discusses donor deferral requirements and sections 610.46–610.47 describe "lookback" procedures.
When a donor tests positive for an infectious disease, the recipients of blood components from previous donations are identified, notified, and, whenever possible, tested to determine if they are positive for the transfusion transmissible disease. If a donor is confirmed positive for HIV, section 610.46 applies. Section 610.47 contains the requirements for notification of the recipients when the donor tests positive for hepatitis C virus (HCV).
These sections outline the time frames for the patient's physician and recipient notifications.
From the transfusion service perspective, the major difference in the lookback process is that in the case of HIV, the relatives must be notified in the event the recipient is deceased.
20. Code of Federal Regulations. Part 610-General Biological Products Standards. Food and Drug Administration, Updated 09 Apr 2024. Available at:https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-610.